05/29/2014 - 10:26am

Mylan on Thursday announced that it has launched atovaquone and proguanil hydrochloride tablets, 62.5 mg/25 mg and 250 mg/100 mg, the generic version of GlaxoSmithKline's Malarone tablets.

05/29/2014 - 9:04am

Teva Pharmaceuticals announced the introduction and availability of dexmethylphenidate hydrochloride extended-release capsules, CII, in 15 mg and 30 mg strengths.

05/27/2014 - 11:00am

Solara Labs on Tuesday announced the launch of its BariMelts line of dietary supplements produced for bariatric surgery patients.

05/27/2014 - 10:20am

Pfizer on Tuesday announced the introduction in the United States of over-the-counter Nexium 24HR, making the "Purple Pill" available for the treatment of frequent heartburn in adults.

05/23/2014 - 6:40pm

The Food and Drug Administration on Friday approved Dalvance (dalbavancin), a new antibacterial drug used to treat adults with acute bacterial skin and skin structure infections.

05/23/2014 - 12:42pm

Omnis Health recently announced the launch of EmbraceEVO, a new blood-glucose meter.

05/23/2014 - 9:48am

Teva Pharmaceutical on Friday announced that the Food and Drug Administration approved the use of QVAR (beclomethasone dipropionate HFA) with a dose counter for the treatment of asthma in patients 5 years of age and older.

05/22/2014 - 3:05pm

QS/1, a healthcare automation solutions provider, announced the release of an iPad app for signature capture.

05/21/2014 - 10:38am

Takeda Pharmaceutical on Tuesday announced that the Food and Drug Administration simultaneously approved a new biologic therapy, Entyvio (vedolizumab), for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease.